ESTA NASDAQ
Credit Risk of going bust: lower than 52% of companies Debt: 11.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.95 (down 99%), Establishment Labs Holdings Inc. would be worth roughly what it owes.
Total debt $263.7M against a stock market value of $1.96B.
Distance to default 5.34 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $130.9M (short-term plus half of long-term), stock volatility 53.5%; Altman Z 2.63. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Austin, TX 78758
US
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Gillin Leslie | A-Award | 262 | $64.17 | 2026-09-30 |
| SCHUTTER EDWARD J | A-Award | 253 | $64.17 | 2026-09-30 |
| LEWIN NICHOLAS SHERI | A-Award | 389 | $64.17 | 2026-09-30 |
| Slotkin Bryan | A-Award | 253 | $64.17 | 2026-09-30 |
| Custin Ann | A-Award | 301 | $64.17 | 2026-09-30 |